Results 221 to 230 of about 102,263 (291)

Population pharmacokinetics of meropenem-vaborbactam in acutely ill hospitalized patients with various degrees of renal dysfunction including continuous renal replacement therapy

Griffin Reed, Adrian Valadez, Brandon Smith, Erin K. McCreary, Ellen G Kline, Michael J. Neely, Kevin M Squires, Ryan K. Shields, Nathaniel J. Rhodes   +8 more
openalex   +1 more source

Amphiphilic nebramine analogs synergize with β-lactam/β-lactamase inhibitor combinations, including cefepime–taniborbactam and meropenem–xeruborbactam against metallo-β-lactamase-carrying Pseudomonas aeruginosa

Christian Lozeau, Danzel Marie Ramirez, Danyel Ramirez, Gulshan Kumar, Rajat Arora, George G. Zhanel, Gilbert Arthur, Frank Schweizer   +7 more
openalex   +2 more sources

Case Report: Delayed-type hypersensitivity reaction to meropenem in an elderly patient-successful management with imipenem-cilastatin. [PDF]

Front Med (Lausanne)
He C, Liu M, Ye J, Zheng H, Yang J, Huang L.   +5 more
europepmc   +1 more source

Role of phenotypic testing in determining the mechanism of resistance in Gram-negative bacilli & risk factors for meropenem resistance

, 2019
Kavita Raja, Molly Antony, R Rani, Gracyamma Bridget   +3 more
openalex   +1 more source

Enzymatic activity of PBP1B is required for growth rate-independent ppGpp-mediated resistance to PBP2 inhibitors in <i>E. coli</i>. [PDF]

J Bacteriol
Anderson SE, Mack IE, Levin PA.
europepmc   +1 more source

In vitro antimicrobial susceptibility data of global meropenem-resistant Acinetobacter baumannii isolates causing pneumonia: Data from the Antimicrobial Testing Leadership and Surveillance Program, 2014–2021, and re-estimations of susceptibility breakpoints and appropriate dosages of important antibiotics for pneumonia treatment

Shun-Chung Hsueh, Yu‐Tsung Huang, Wen‐Chien Ko, I-Min Liu, Po-Chuen Hsieh, Shio-Shin Jean   +5 more
openalex   +1 more source

Antimicrobial Resistance Profiles of <i>Pseudomonas aeruginosa</i> in a Korean Community Hospital: <i>In Vitro</i> Activity of Ceftazidime-Avibactam and Other Agents. [PDF]

Pol J Microbiol
Lee HJ, Cho SY, Lee DG, Park C, Byun J, Chun HS, Kim YR.   +6 more
europepmc   +1 more source

IncL plasmid-mediated dissemination of OXA-48 β-lactamase and <i>bla</i> _CTX-M-15 gene amplification identified <i>via</i> long-read sequencing in carbapenem-resistant Enterobacterales. [PDF]

JAC Antimicrob Resist
Prasad S, Dratvova B, Gryndlerova A, Brajerova M, Kabelikova P, Tkadlec J, Drevinek P, Krutova M.   +7 more
europepmc   +1 more source

Structure-DirectedOptimization of Ebselen Derivativesas Potent NDM‑1 Inhibitors Reverses Meropenem Resistance

Yan Guo (83742), Chenyu Liu (1549891), Wandong Liu (22612004), Chen Zhang (66790), Zhiying Liu (350234), Shengbiao Wan (1852087), Ximing Xu (401171), Sheng Chen (21971), Jiazhang Qiu (232733)   +8 more
openalex   +1 more source

Drug-Induced Liver Injury Secondary to Meropenem: Diagnostic Challenge and Therapeutic Role of Hemoadsorption. [PDF]

Cureus
Simões L, Sequeira M, Silva C, Monteiro C.   +3 more
europepmc   +1 more source